News
China NMPA accepts Hutchmed & Innovent’s NDA for fruquintinib in combo with sintilimab to treat advanced renal cell carcinoma: Hong Kong, Shanghai Friday, June 6, 2025, 09:00 Hr ...
Among individuals with achalasia, male sex, older age and prior esophageal Candida infection increased risk for esophageal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback